{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:09:46Z","timestamp":1771675786549,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.vaccine.2021.06.019","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T13:35:51Z","timestamp":1623850551000},"page":"4261-4265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical and molecular characterization of the first culture-confirmed pediatric fulminant meningococcemia case caused by a serogroup Y clonal complex 23 strain in China"],"prefix":"10.1016","volume":"39","author":[{"given":"Xiangshi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2707-9471","authenticated-orcid":false,"given":"Mingliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.06.019_b0005","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/cid\/cix993","article-title":"Current epidemiology and trends in meningococcal disease-United States, 1996\u20132015","volume":"66","author":"MacNeil","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.019_b0010","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1080\/21645515.2015.1051276","article-title":"Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013","volume":"11","author":"Broker","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.06.019_b0015","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/jac\/dkab010","article-title":"Emergence of MDR invasive Neisseria meningitidis in El Salvador, 2017\u201319","volume":"76","author":"Marin","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2021.06.019_b0020","first-page":"22","article-title":"WGS analysis of a penicillin-resistant Neisseria meningitidis strain containing a chromosomal ROB-1 beta-lactamase gene","volume":"74","author":"Tsang","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2021.06.019_b0025","doi-asserted-by":"crossref","first-page":"e00831","DOI":"10.1128\/AAC.00831-18","article-title":"Acquisition of Beta-Lactamase by Neisseria meningitidis through Possible Horizontal Gene Transfer","volume":"62","author":"Hong","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2021.06.019_b0030","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab358","article-title":"Acquisition of ciprofloxacin resistance among an expanding clade of beta-lactamase positive, serogroup Y Neisseria meningitidis in the United States","author":"Potts","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.019_b0035","first-page":"825","article-title":"Epidemiological analysis on serogroup Y Neisseria meningitidis firstly isolated from patient in Tianjin","volume":"50","author":"Guo","year":"2016","journal-title":"Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]"},{"key":"10.1016\/j.vaccine.2021.06.019_b0040","first-page":"612","article-title":"The molecular characteristics of Neisseria meningitidis serogroup Y clonal complex 23 first emerge in China","volume":"79","author":"Li","year":"2019","journal-title":"J infect"},{"key":"10.1016\/j.vaccine.2021.06.019_b0045","first-page":"482","article-title":"Epidemiological characteristics of meningococcal meningitis and switching trend of serogroups of Neisseria meningitidis in China, 2006\u20132014","volume":"21","author":"Li","year":"2015","journal-title":"Chin J Vaccine Immun"},{"key":"10.1016\/j.vaccine.2021.06.019_b0050","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing: twenty-nineth informational supplement. CLSI document M100-S29. Wayne, PA: Clinical and Laboratory Standards Institute; 2019"},{"key":"10.1016\/j.vaccine.2021.06.019_b0055","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1128\/AAC.00412-07","article-title":"Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis","volume":"51","author":"Taha","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2021.06.019_b0060","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1186\/1471-2164-15-1138","article-title":"A gene-by-gene population genomics platform: de novo assembly, annotation and genealogical analysis of 108 representative Neisseria meningitidis genomes","volume":"15","author":"Bratcher","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.vaccine.2021.06.019_b0065","unstructured":"Chinese Preventive Medicine Association. [Experts' consensus on immunization with meningococcal vaccines in China]. Zhonghua liu xing bing xue za zhi. 2019;40:123-8"},{"key":"10.1016\/j.vaccine.2021.06.019_b0070","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3201\/eid1909.130160","article-title":"Spread of Neisseria meningitidis serogroup W clone, China.","volume":"19","author":"Zhou","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.019_b0075","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1017\/S0950268814000259","article-title":"Secular trends in invasive meningococcal disease, Massachusetts, 1988\u20132011: what happened to invasive disease?","volume":"142","author":"Peruski","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2021.06.019_b0080","doi-asserted-by":"crossref","first-page":"e35699","DOI":"10.1371\/journal.pone.0035699","article-title":"Whole genome sequencing to investigate the emergence of clonal complex 23 Neisseria meningitidis serogroup Y disease in the United States","volume":"7","author":"Krauland","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21007556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21007556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:56:54Z","timestamp":1759402614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21007556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":16,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0264410X21007556"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and molecular characterization of the first culture-confirmed pediatric fulminant meningococcemia case caused by a serogroup Y clonal complex 23 strain in China","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}